Hemostasis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model
Summary Hemostasis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The increasing prevalence of surgical cases and rises in venous thromboembolism (VTE) incidence represent major driving factors for the hemostasis testing market.Prothrombin (PT) and Activated Prothrombin (aPTT) tests represent the most widely used Hemostasis tests.
These devices are frequently utilized for coagulation testing prior to surgery while D-Dimer tests tend to be performed in VTE or suspected VTE cases.
PT tests are also frequently used for monitoring of patients taking vitamin K antagonists such as warfarin, phenprocoumon, and acenocoumarol. Additionally, aPTT tests are used for monitoring of patients taking unfractionated heparin, which is a commonly prescribed anticoagulant in China and India.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).
Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model
Currently marketed Hemostasis Tests and evolving competitive landscape - - Insightful review of the key industry trends. - Annualized total Hemostasis Tests market revenue by segment and market outlooks from 2015-2028. - Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights - - Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market. - SWOT analysis for this Hemostasis Tests market. - Competitive dynamics insights and trends provided for this Hemostasis Tests market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. - Country specific overview of the healthcare system. - Country specific reimbursement policies. - Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.
In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope This Market Model gives important, expert insight you won’t find in any other source.
The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for - - CMO executives who must have deep understanding of the Hematology Analyzers marketplace to make strategic planning and investment decisions. - Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. - Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to buy The model will enable you to - - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving Hemostasis Tests market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hemostasis Tests market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Track device sales in the global and country-specific Hemostasis Tests market from 2015-2028. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Our reports have been used by over 10K customers, including:
Global Beta-2 Microglobulin Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover...
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage. The report provides...
German In Vitro Diagnostics Market for 500 Tests: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Business Environment, Market Structure This new report provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers,...
The Global Oncology Partnering 2014-2019: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Oncology partnering deals Financial deal terms for headline, upfront and royalty...
180 pages •
By Global Industry Analysts
• Oct 2019
Kidney/Renal Function Test market worldwide is projected to grow by US$274.4 Million, driven by a compounded growth of 5.8%. Dipsticks, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast...
247 pages •
By Global Industry Analysts
• Oct 2019
RSV Diagnostics market worldwide is projected to grow by US$568.5 Million, driven by a compounded growth of 9.8%. Kits & Assays, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.